SCHEMBL2921901

SCHEMBL2921901

C=CCC[C@@H](C)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL466704 1.00
SCHEMBL2928722 1.00
SCHEMBL3447382 0.85
SCHEMBL3447384 0.85
SCHEMBL20526060 0.83 TSHR (0.42)
SCHEMBL3250029 0.83 TSHR (0.42)
SCHEMBL3119034 0.82
SCHEMBL9333745 0.82
SCHEMBL20526052 0.78 ALOX15 (0.43)
Allyl Alcohol SCHEMBL28659767 0.77 TSHR (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119798181-A (R) -4-isopropyl-3- ((R) -2-methyl-5-hexenoyl) oxazolidin-2-one and application thereof in synthesis of inchworm sex pheromone component of Western iron yew 山东省农业科学院 2025-04-11 CN claimed
CN-119798181-A (R) -4-isopropyl-3- ((R) -2-methyl-5-hexenoyl) oxazolidin-2-one and application thereof in synthesis of inchworm sex pheromone component of Western iron yew 山东省农业科学院 2025-04-11 CN disclosed
EP-2076278-B1 Macrocyclic HCV NS3 protease inhibitors MERCK SHARP & DOHME (US) 2015-05-06 EP disclosed
EP-2083844-B1 HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2013-11-27 EP disclosed
US-8377874-B2 HCV NS3 protease inhibitors MERCK SHARP & DOHME CORP. (US) 2013-02-19 US disclosed
US-8377873-B2 HCV NS3 protease inhibitors MERCK SHARP & DOHME CORP. (US) 2013-02-19 US disclosed
US-20100298210-A1 HCV NS3 Protease Inhibitors MERCK SHARP & DOHME LLC 2010-11-25 US disclosed
US-20100286185-A1 HCV NS3 Protease Inhibitors MERCK SHARP & DOHME LLC 2010-11-11 US disclosed
WO-2008051477-A2 HCV NS3 PROTEASE INHIBITORS MERCK & CO., INC. (US) 2008-05-02 WO disclosed